SEARCH

SEARCH BY CITATION

References

  • Abe, M., Tanaka, Y., Shinohara, M., Kosaka, M. & Matsumoto, T. (2000) Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites. British Journal of haematology, 111, 712713.
  • Bandipalliam, P. (2005) Syndrome of early onset colon cancers, haematological malignancies and features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Familial Cancer, 4, 323333.
  • Coldron, J. & Reid, I. (2001) Muir- Torre Syndrome. Journal of Royal College of Surgeons Edinburgh, 46, 178179.
  • Kayser, S., Döhner, K., Krauter, J., Köhne, C.-H., Horst, H.A., Held, G., von Lilienfeld-Toal, M., Wilhelm, S., Kündgen, A., Götze, K., Rummel, M., Nachbaur, D., Schlegelberger, B., Göhring, G., Späth, D., Morlok, C., Zucknick, M., Ganser, A., Döhner, H., Schlenk, R.F. & for the German-Austrian AMLSG. (2011) The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood, 117, 21372145.
  • Lowsky, R., Lipton, J., Fyles, G., Minden, M., Meharchand, J., Tejpar, I., Atkins, H., Sutcliffe, S. & Messner, H. (1994) Secondary malignancies after bone marrow transplantation in adults. Journal of Clinical Oncology, 1, 21872192.
  • Mao, G., Yuan, F., Absher, K., Jennings, C.D., Howard, D.S., Jordan, C.T. & Gu, L. (2008) Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukaemia: potential contribution to AML progression. Cell Research, 18, 281289.
  • Scott, R.H., Mansour, S., Pritchard-Jones, K., Kumar, D., MacSweeney, F. & Rahman, N. (2007) Medulloblastoma, acute myelocytic leukaemia and colonic carcinomas in a child with biallelic MSH6 mutations. Nature Clinical Practice Oncology, 4, 130134.
  • Syngal, S. (2000) Hereditary nonpolyposis colorectal cancer: a call for attention. Journal of Clinical Oncology, 18, 21892192.